We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Synlab AG (SYAB) NPV

Sell:€10.38 Buy:€10.58 Change: €0.04 (0.38%)
Market closed |  Prices as at close on 25 April 2024 | Switch to live prices |
Sell:€10.38
Buy:€10.58
Change: €0.04 (0.38%)
Market closed |  Prices as at close on 25 April 2024 | Switch to live prices |
Sell:€10.38
Buy:€10.58
Change: €0.04 (0.38%)
Market closed |  Prices as at close on 25 April 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Synlab AG is a Germany based clinical laboratory and medical diagnostic services provider. The Company is engaged in laboratory services for human and veterinary medicine, as well as environmental analysis.

Contact details

Address:
Moosacher Strasse 88
MUENCHEN
80809
Germany
Telephone:
+49 (89) 3076020
Website:
https://ag.synlab.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
SYAB
ISIN:
DE000A2TSL71
Market cap:
€2.34 billion
Shares in issue:
219.78 million
Sector:
Health Care Services
Exchange:
Frankfurt Stock Exchange
Country:
Germany
Currency:
Euro
Indices:
n/a

Key personnel

  • David Ebsworth
    Independent Chairman of the Supervisory Board
  • Mathieu Floreani
    Chief Executive Officer, Member of the Management Board
  • Marc Welters
    Deputy Chairman of the Supervisory Board
  • Sami Badarani
    Chief Financial Officer, Member of the Management Board
  • Rainar Aamisepp
    Chief Executive Officer of SYNLAB North and East
  • Stephan Brune
    Chief Executive Officer of SYNLAB South
  • Sebastien Gibault
    Chief Executive Officer of SYNLAB France
  • Christoph Mahnke
    Chief Executive Officer of SYNLAB Germany
  • Robert Steinwander
    Chief Operating Officer
  • Catharina Monster
    Chief Human Resource Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.